Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

GLP-1 Receptor Targeting in Diabetic and Healthy Individuals

Completed

Conditions: Type 1 Diabetes

Interventions: Other: radiolabeled Exendin

First Posted Date: 2013-04-05

Last Posted Date: 2014-12-02

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT01825148

Locations: 🇳🇱
Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, Netherlands

Experimental Human Rhinovirus Infection

Phase 1

Completed

Conditions: Common Cold

Interventions: Other: placebo
Other: Human Rhinovirus strain 16 (HRV-16)

First Posted Date: 2013-04-04

Last Posted Date: 2014-10-15

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT01823640

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

FertiScreen: an Online Application to Improve the Quality of Fertility Care

Not Applicable

Conditions: Unexplained Subfertile Couples With a Good Prognosis.

Interventions: Other: FertiScreen

First Posted Date: 2013-03-28

Last Posted Date: 2013-12-16

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 152

Registration Number: NCT01820039

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, PO Box 9101, Netherlands

Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy

Phase 4

Completed

Conditions: Chronic Central Serous Chorioretinopathy

Interventions: Procedure: Micropulse laser (ML) treatment
Procedure: Half-dose photodynamic therapy (PDT)

First Posted Date: 2013-02-25

Last Posted Date: 2017-10-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 140

Registration Number: NCT01797861

Locations: 🇬🇧
Oxford University Eye Hospital, John Radcliffe Hospital, Oxford, United Kingdom
🇩🇪
Cologne University Eye Clinic, Cologne, Germany
🇳🇱
Leiden University Medical Center, Leiden, Netherlands

and more 2 locations

Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases

Not Applicable

Recruiting

Conditions: Multi-organ Metastatic Colorectal Cancer

Interventions: Drug: XELOX regimen according to standard procedures
Drug: FOLFOX regimen according to standard procedures
Procedure: Surgery
Procedure: tumor biopsy
Other: radiofrequency ablation (RFA)
Other: transarterial chemo-embolization using irinotecan drug-eluted beads ((DEBIRI-)TACE)
Radiation: stereotactic body radiation therapy (SBRT)
Drug: Bevacizumab

First Posted Date: 2013-02-15

Last Posted Date: 2023-04-21

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 478

Registration Number: NCT01792934

Locations: 🇳🇱
Amstelveen Ziekenhuis, Amstelveen, Netherlands
🇳🇱
VU Medical Center, Amsterdam, Netherlands
🇳🇱
Sint Antonius Ziekenhuis, Nieuwegein, Netherlands

and more 26 locations

The Senior Step Study How Elderly Help Themselves Maximally Forward

Not Applicable

Completed

Conditions: Self-management for Mobility Improvement in the Elderly

Interventions: Behavioral: Mobility feedback device with use of instruction book

First Posted Date: 2013-02-15

Last Posted Date: 2018-08-29

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 150

Registration Number: NCT01792180

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

Perioperative Δ9-THC for Postsurgical Pain

Phase 2

Conditions: Pain

Interventions: Drug: Diazepam/placebo
Drug: Namisol

First Posted Date: 2013-02-13

Last Posted Date: 2013-10-23

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT01790555

Locations: 🇳🇱
Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, Netherlands

pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for Delirium

Phase 4

Completed

Conditions: Delirium

Interventions: Drug: Haloperidol 2 mg/q8h
Drug: Haloperidol 1 mg/q8h
Drug: Placebo

First Posted Date: 2013-02-07

Last Posted Date: 2020-11-12

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 1800

Registration Number: NCT01785290

Locations: 🇳🇱
Radboud University Medical Centre, Nijmegen, Netherlands

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis

Phase 1

Withdrawn

Conditions: Malaria, Falciparum

Interventions: Drug: Azithromycin capsules
Drug: Placebo
Biological: Immunization with falciparum

First Posted Date: 2013-02-04

Last Posted Date: 2014-11-13

Lead Sponsor: Radboud University Medical Center

Registration Number: NCT01783340

Locations: 🇳🇱
Leiden University Medical Centre, Leiden, Netherlands

Pharmacokinetics of Micafungin in Patients Intensive Care Unit

Completed

Conditions: Invasive Fungal Infection

Interventions: Drug: micafungin

First Posted Date: 2013-02-04

Last Posted Date: 2020-11-30

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT01783379

Locations: 🇳🇱
Rijstate Hospital, Arnhem, Netherlands
🇳🇱
Gelderse Vallei Hospital, Ede, Netherlands
🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy